- Home
- CDNA vs MMI Comparison
CDNA vs MMI Comparison
Compare CDNA & MMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- MMI
- Stock Information
- Founded
- CDNA 1998
- MMI 1971
- Country
- CDNA United States
- MMI United States
- Employees
- CDNA N/A
- MMI N/A
- Industry
- CDNA Medical Specialities
- MMI Real Estate
- Sector
- CDNA Health Care
- MMI Finance
- Exchange
- CDNA Nasdaq
- MMI Nasdaq
- Market Cap
- CDNA 1.0B
- MMI 1.2B
- IPO Year
- CDNA 2014
- MMI 2013
- Fundamental
- Price
- CDNA $15.00
- MMI $30.67
- Analyst Decision
- CDNA Buy
- MMI Sell
- Analyst Count
- CDNA 8
- MMI 1
- Target Price
- CDNA $28.14
- MMI $30.00
- AVG Volume (30 Days)
- CDNA 940.1K
- MMI 126.0K
- Earning Date
- CDNA 04-30-2025
- MMI 05-07-2025
- Dividend Yield
- CDNA N/A
- MMI 1.63%
- EPS Growth
- CDNA N/A
- MMI N/A
- EPS
- CDNA 1.07
- MMI N/A
- Revenue
- CDNA $346,421,000.00
- MMI $696,060,000.00
- Revenue This Year
- CDNA $13.28
- MMI $11.69
- Revenue Next Year
- CDNA $15.13
- MMI $24.07
- P/E Ratio
- CDNA $13.96
- MMI N/A
- Revenue Growth
- CDNA 25.92
- MMI 7.76
- 52 Week Low
- CDNA $7.42
- MMI $29.36
- 52 Week High
- CDNA $34.84
- MMI $42.80
- Technical
- Relative Strength Index (RSI)
- CDNA 31.37
- MMI 39.13
- Support Level
- CDNA $14.86
- MMI $29.72
- Resistance Level
- CDNA $18.71
- MMI $31.02
- Average True Range (ATR)
- CDNA 0.98
- MMI 0.81
- MACD
- CDNA -0.24
- MMI 0.16
- Stochastic Oscillator
- CDNA 3.08
- MMI 41.67
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About MMI Marcus & Millichap Inc.
Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.